Treatment of refractory large granular lymphocytic leukemia with 2‐chlorodeoxyadenosine

M. Edelman,R. O'donnell,Ivan Meadows
DOI: https://doi.org/10.1002/(SICI)1096-8652(199704)54:4<329::AID-AJH13>3.0.CO;2-6
1997-04-01
Abstract:A 50‐year‐old man with large granular lymphocytic leukemia (CD3+, CD8+) complicated by severe pancytopenia and life‐threatening infections refractory to therapy with prednisone, methotrexate, cyclosporine, and G‐CSF is described. Treatment with two cycles of 2‐chlorodeoxyadenosine (2‐CDA) at 0.1 mg/kg by continuous intravenous infusion for 7 days each cycle resulted in resolution of cytopenias and clearance of leukemic cells. T‐cell receptor gene rearrangement, initially present, was not detectable after therapy with 2‐CDA. The rapid and complete response to 2‐CDA after unsuccessful attempts with prior therapy suggests that 2‐CDA should be considered for initial treatment of this disorder. Am. J. Hematol. 54:329–331, 1997. © 1997 Wiley‐Liss, Inc.
What problem does this paper attempt to address?